Aijun Shen
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
- Heat shock proteins research
- Glycosylation and Glycoproteins Research
- Metabolomics and Mass Spectrometry Studies
Papers in
-
- Protein Degradation and Inhibitors 9
- Histone Deacetylase Inhibitors Research 9
- Heat shock proteins research 8
- Fibroblast Growth Factor Research 3
- ATP Synthase and ATPases Research 3
- Oncology 9
- Peptidase Inhibition and Analysis 5
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Meiyu Geng (25 shared papers)Jian Ding (12 shared papers)Min Huang (7 shared papers)Hong‐Chun Liu (19 shared papers)Jian Qiao (5 shared papers)Anli Zhang (4 shared papers)Zhida Liu (4 shared papers)Chuanhui Han (4 shared papers)
- Journals
- European Journal of Medicinal Chemistry (6 papers)Journal of Medicinal Chemistry (4 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Acta Pharmacologica Sinica (3 papers)Clinical Cancer Research (2 papers)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Aijun Shen
38 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 101
- Cancer Research 233
- Molecular Biology 1.0k
- Oncology 326
- Immunology 253
- Toxicology 41
Countries citing papers authored by Aijun Shen
This map shows the geographic impact of Aijun Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aijun Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aijun Shen more than expected).
Fields of papers citing papers by Aijun Shen
This network shows the impact of papers produced by Aijun Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aijun Shen. The network helps show where Aijun Shen may publish in the future.
Co-authors
The 25 scholars most cited alongside Aijun Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 229 | |
| 2 | 2021 | 128 | |
| 3 | 2020 | 122 | |
| 4 | 2017 | 99 | |
| 5 | 2013 | 96 | |
| 6 | 2013 | 96 | |
| 7 | 2019 | 75 | |
| 8 | 2013 | 63 | |
| 9 | 2016 | 52 | |
| 10 | 2020 | 49 | |
| 11 | 2020 | 44 | |
| 12 | 2017 | 42 | |
| 13 | 2015 | 41 | |
| 14 | 2018 | 41 | |
| 15 | 2016 | 37 | |
| 16 | 2019 | 35 | |
| 17 | 2017 | 34 | |
| 18 | 2014 | 33 | |
| 19 | 2016 | 29 | |
| 20 | 2018 | 28 |
About Aijun Shen
Aijun Shen is a scholar working on Molecular Biology, Oncology, Immunology, Computational Theory and Mathematics and Cell Biology, having authored 39 papers that have together received 1.6k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (9 papers), Histone Deacetylase Inhibitors Research (9 papers), Heat shock proteins research (8 papers), Peptidase Inhibition and Analysis (5 papers), Computational Drug Discovery Methods (4 papers), Fibroblast Growth Factor Research (3 papers), ATP Synthase and ATPases Research (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Cancer Research (233 citations), Molecular Biology (1.0k citations), Oncology (326 citations), Immunology (253 citations) and Toxicology (41 citations). Aijun Shen has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Meiyu Geng, Jian Ding, Min Huang, Hong‐Chun Liu, Jian Qiao, Anli Zhang, Zhida Liu, Chuanhui Han, Ou Huang and Kunwei Shen. Their work appears in journals such as European Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Acta Pharmacologica Sinica and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.